Tenders/Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for the active ingredient Pegfilgrastim, ATC L03AA13 for the period 01.01.2027 - 31.12.2027 (plus 1x12 months extension option)
Open🇩🇪GermanySupplies

Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for the active ingredient Pegfilgrastim, ATC L03AA13 for the period 01.01.2027 - 31.12.2027 (plus 1x12 months extension option)

Auto-translated from German
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.01.2027 - 31.12.2027 (zzgl. Verlängerungsoption 1x12 Monate)
DAK-Gesundheit
Published: Oct 19, 2026
Updated: Oct 22, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Auto-translated from German
The ARGE-OH-BioTech Pegfilgrastim assumes that this procedure does not fall within the scope of cartel public procurement law due to a lack of selection decision and thus the non-discriminatory access possibility for all pharmaceutical companies. Regardless, it automatically ends with the entry into force of the exclusive contract for Pegfilgrastim, ATC L03AA13 as a result of a formal procurement procedure according to the regulations of the 4th part of the GWB with one or more contracting partners. In order to do justice to the diversity of potential contracting partners within the framework of the approval model, every pharmaceutical company will be enabled to conclude a framework agreement at any time and under the same conditions during the contract term. The necessary contract documents for this are available for download via the online portal www.dtvp.de/center under the link mentioned in 5.1.11. Prerequisites for the conclusion, or later accession to the contracts that initially come into force on 01.01.2027, is the complete and timely submission of the following documents (available for download under the link mentioned in 5.1.11) to the following department at DAK-Gesundheit: 1. Offer letter 2. Acceptance of the contractual provisions of DAK-Gesundheit, especially also the specified discounts by submitting the contract signed by name or company stamp by the interested party in the designated place. 3. The completed Annexes 1 and 2 to the contract. The interested party must enter the medicines for the above-mentioned active ingredient here, which are to become the subject of the contract. The documents are to be submitted PER E-MAIL to: openhouse@dak.de DAK-Gesundheit Department of Medicines (0032 20) Nagelsweg 27-31 20097 Hamburg Annex 2 must be explicitly sent as an Excel file to the e-mail address openhouse@dak.de. Contracts within the framework of this model and for the above-mentioned active ingredient will be concluded for the first time with effect from 01.01.2027. Interested parties who want to become contracting partners by this date must submit the above-mentioned documents to be submitted to the above-mentioned office by 19.11.2026 (6 weeks before contract start). The offer must be submitted in text form as an electronic offer PER E-MAIL to openhouse@dak.de. Submission of the offer by post is not provided for in this procedure. Please do NOT submit the offer via the German Procurement Portal. For timely submission, electronic receipt of all documents by e-mail to the e-mail address openhouse@dak.de is sufficient. Timely receipt by DAK-Gesundheit is decisive here. Later accessions are possible at any time. In order to join on the 1st or 15th of the following month during the contract term, the documents specified above must be available to DAK-Gesundheit by e-mail 6 weeks before the contract start. Here too, timely receipt by DAK-Gesundheit is decisive. For timely submission, electronic receipt (e-mail) of all documents is sufficient. The interested party must enter the desired contract start date in "Annex 2 to the Drug Discount Agreement according to § 130a Para. 8". Example: The desired contract start by the interested party is to take place on 01.06.2027, the documents would have to be available by 19.04.2027 for this. Note: The publication is made here using the form for open procedures. As already made clear, this is not one - the notice had to be used for technical reasons, as there is no suitable form for approval procedures.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 19, 2026. Last refreshed 27 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About DAK-Gesundheit

DAK-Gesundheit has issued 328 procurement notices on BidsFactory, including 145 currently open and 110 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU), service.bund.de (Germany), and DÖE Bekanntmachungsservice (Germany). Most recent publication: November 17, 2026.

DAK-Gesundheit: buyer profile, tenders and awards

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by DAK-Gesundheit in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
German

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

DAK-Gesundheit
🇩🇪Germany